← All companiesSSpyre Therapeutics, Inc.
SYRE - CIK 0001636282
Spyre Therapeutics, Inc. net income by year
Spyre Therapeutics, Inc. (SYRE) reported net income of -$155.20M for fiscal year 2025, as filed in its audited annual report with the SEC.
SYRE annual net income
SYRE net income 2014-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$155.20M | +25.4% |
| FY 2024 | -$208.02M | +38.6% |
| FY 2023 | -$338.79M | -304.2% |
| FY 2022 | -$83.81M | -27.4% |
| FY 2021 | -$65.80M | +18.7% |
| FY 2020 | -$80.89M | -3.4% |
| FY 2019 | -$78.25M | -76.5% |
| FY 2018 | -$44.35M | -62.8% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Spyre Therapeutics, Inc. make?
Spyre Therapeutics, Inc. (SYRE) reported net income of -$155.20M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Spyre Therapeutics, Inc.'s net income changed over time?
Between fiscal 2014 and fiscal 2025, Spyre Therapeutics, Inc.'s net income declined from -$10.35M to -$155.20M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.